Torrent Pharmaceuticals Future Growth
Future criteria checks 5/6
Torrent Pharmaceuticals is forecast to grow earnings and revenue by 21.3% and 11.6% per annum respectively. EPS is expected to grow by 21.6% per annum. Return on equity is forecast to be 33.4% in 3 years.
Key information
21.3%
Earnings growth rate
21.6%
EPS growth rate
Pharmaceuticals earnings growth | 18.7% |
Revenue growth rate | 11.6% |
Future return on equity | 33.4% |
Analyst coverage | Good |
Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 150,725 | 30,361 | 31,749 | N/A | 1 |
3/31/2026 | 137,315 | 25,454 | 28,988 | N/A | 26 |
3/31/2025 | 121,959 | 20,552 | 24,913 | N/A | 28 |
3/31/2024 | 108,151 | 16,431 | 21,949 | N/A | 29 |
12/31/2023 | 104,742 | 14,942 | N/A | N/A | N/A |
9/30/2023 | 102,332 | 13,432 | 24,212 | 28,691 | N/A |
6/30/2023 | 98,642 | 12,692 | N/A | N/A | N/A |
3/31/2023 | 96,202 | 12,452 | 17,942 | 23,681 | N/A |
12/31/2022 | 92,580 | 8,312 | N/A | N/A | N/A |
9/30/2022 | 88,750 | 7,972 | 15,574 | 19,380 | N/A |
6/30/2022 | 87,210 | 8,012 | N/A | N/A | N/A |
3/31/2022 | 85,080 | 7,772 | 16,004 | 18,030 | N/A |
12/31/2021 | 83,158 | 12,189 | N/A | N/A | N/A |
9/30/2021 | 82,028 | 12,669 | 15,015 | 17,827 | N/A |
6/30/2021 | 80,828 | 12,609 | N/A | N/A | N/A |
3/31/2021 | 80,046 | 12,519 | 16,702 | 20,054 | N/A |
12/31/2020 | 80,143 | 12,417 | N/A | N/A | N/A |
9/30/2020 | 79,853 | 11,957 | 13,690 | 18,078 | N/A |
6/30/2020 | 79,733 | 11,297 | N/A | N/A | N/A |
3/31/2020 | 79,393 | 10,247 | 9,861 | 13,929 | N/A |
12/31/2019 | 78,488 | 5,593 | N/A | N/A | N/A |
9/30/2019 | 79,338 | 5,543 | 10,463 | 16,981 | N/A |
6/30/2019 | 78,228 | 4,893 | N/A | N/A | N/A |
3/31/2019 | 76,728 | 4,363 | 11,353 | 17,981 | N/A |
12/31/2018 | 75,141 | 8,161 | N/A | N/A | N/A |
9/30/2018 | 69,891 | 6,281 | N/A | N/A | N/A |
6/30/2018 | 65,121 | 6,531 | N/A | N/A | N/A |
3/31/2018 | 59,498 | 6,781 | 1,029 | 8,942 | N/A |
12/31/2017 | 56,727 | 6,556 | N/A | N/A | N/A |
9/30/2017 | 56,387 | 8,266 | N/A | N/A | N/A |
6/30/2017 | 56,387 | 8,296 | N/A | N/A | N/A |
3/31/2017 | 58,157 | 9,336 | N/A | 10,088 | N/A |
12/31/2016 | 59,154 | 10,014 | N/A | N/A | N/A |
9/30/2016 | 60,144 | 10,624 | N/A | N/A | N/A |
6/30/2016 | 62,744 | 13,644 | N/A | N/A | N/A |
3/31/2016 | 66,669 | 17,332 | N/A | 27,421 | N/A |
12/31/2015 | 63,315 | 16,299 | N/A | N/A | N/A |
9/30/2015 | 59,605 | 13,139 | N/A | N/A | N/A |
6/30/2015 | 54,865 | 9,439 | N/A | N/A | N/A |
3/31/2015 | 46,535 | 7,509 | N/A | 8,102 | N/A |
12/31/2014 | 47,247 | 8,649 | N/A | N/A | N/A |
9/30/2014 | 45,717 | 8,559 | N/A | N/A | N/A |
6/30/2014 | 43,267 | 7,709 | N/A | N/A | N/A |
3/31/2014 | 41,847 | 6,639 | N/A | 5,994 | N/A |
12/31/2013 | 38,291 | 5,308 | N/A | N/A | N/A |
9/30/2013 | 36,111 | 4,858 | N/A | N/A | N/A |
6/30/2013 | 33,781 | 4,798 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 500420's forecast earnings growth (21.3% per year) is above the savings rate (6.7%).
Earnings vs Market: 500420's earnings (21.3% per year) are forecast to grow faster than the Indian market (17.5% per year).
High Growth Earnings: 500420's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 500420's revenue (11.6% per year) is forecast to grow faster than the Indian market (10% per year).
High Growth Revenue: 500420's revenue (11.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 500420's Return on Equity is forecast to be high in 3 years time (33.4%)